KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to 0.47.

  • Jazz Pharmaceuticals' Debt Ratio fell 533.61% to 0.47 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47, marking a year-over-year decrease of 533.61%. This contributed to the annual value of 0.51 for FY2024, which is 141.73% up from last year.
  • As of Q3 2025, Jazz Pharmaceuticals' Debt Ratio stood at 0.47, which was down 533.61% from 0.49 recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Debt Ratio peaked at 0.55 during Q3 2022, and registered a low of 0.31 during Q1 2021.
  • For the 5-year period, Jazz Pharmaceuticals' Debt Ratio averaged around 0.5, with its median value being 0.5 (2024).
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Debt Ratio surged by 6455.05% in 2022, and later tumbled by 769.83% in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Debt Ratio (Quarter) stood at 0.49 in 2021, then increased by 7.4% to 0.53 in 2022, then dropped by 5.09% to 0.5 in 2023, then rose by 1.42% to 0.51 in 2024, then dropped by 7.17% to 0.47 in 2025.
  • Its last three reported values are 0.47 in Q3 2025, 0.49 for Q2 2025, and 0.47 during Q1 2025.